Illumina held a webinar comparing Illumina TruPath Genome to long-read approaches and proximity mapped reads.
Published
Signal category
Presence & Recognition
Quote
“Check out this webinar comparing Illumina TruPath™ Genome to long-read approaches and see what's possible with proximity mapped reads.”
— Mihir Shanishchara|Illumina team
Company
Illumina
Unlocking the Power of the Genome
- Industry
- Biotechnology Research
- Location
- San Diego, US
- Company size
- 9,689 employees
At Illumina, our goal is to apply innovative technologies and revolutionary assays to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. These studies will help make the realization of personalized medicine possible. With such rapid advances in technology taking place, it is mission critical to have solutions that are not only innovative, but flexible, scalable, and complete with industry-leading support and service. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and prioritizing the needs of its customers, we strive to meet this challenge. Illumina’s innovative, array-based solutions for DNA, RNA, and protein analysis serve as tools for disease research, drug development, and the development of molecular tests in the clinic.
Founded 1998